Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | SI | P14410 | 2/20 | 0.55 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3197986 | 1.00 | — | — | |
| SCHEMBL180823 | 0.97 | — | — | |
| SCHEMBL31290754 | 0.97 | MGAM (0.58) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL3181134 | 0.94 | — | — | |
| SCHEMBL28356244 | 0.94 | — | — | |
| SCHEMBL25276833 | 0.94 | — | — | |
| Malonic Acid SCHEMBL4212077 | 0.94 | LDHA (0.56) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL2846065 | 0.94 | — | — | |
| SCHEMBL29002113 | 0.94 | MGAM (0.55) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1463993 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140335406-A1 | NON-AQUEOUS ORGANIC ELECTROLYTE ADDITIVE, METHOD FOR PREPARING NON-AQUEOUS ORGANIC ELECTROLYTE ADDITIVE, NON-AQUEOUS ORGANIC ELECTROLYTE, AND LITHIUM-ION SECONDARY BATTERY | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2014-11-13 | — | — | US | disclosed |
| EP-2768066-A1 | NONAQUEOUS ORGANIC ELECTROLYTE ADDITIVE AND PREPARATION METHOD THEREOF, NONAQUEOUS ORGANIC ELECTROLYTE, AND LITHIUM ION SECONDARY BATTERY | Huawei Technologies Co., Ltd. (CN) | 2014-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335406-A1 | NON-AQUEOUS ORGANIC ELECTROLYTE ADDITIVE, METHOD FOR PREPARING NON-AQUEOUS ORGANIC ELECTROLYTE ADDITIVE, NON-AQUEOUS ORGANIC ELECTROLYTE, AND LITHIUM-ION SECONDARY BATTERY | HCN2, VDAC1, HCN1 | MGAM 3630/4885GAA 3257/4885SI 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.